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Objective: To evaluate the clinical significance of and describe factors associated with Corynebacteriurn striaturn 
infection. 
Methods: A retrospective chart review was performed of the C. striaturn isolated in a university hospital from January 
1991 to July 1995. C. striaturn was identified using conventional methods, the API CORYNE system and cellular fatty 
acid profiles. 
Results: In the study period, C. striaturn was isolated from clinical samples in 127 patients. In 49 patients, data from 
clinical charts were considered insufficient for evaluation. In 26 cases, the microorganism was considered to  be the 
etiologic agent of an infectious process. In the remaining 52 patients, the organism was considered to  be a colonizer. 
Before the infection all the patients had been hospitalized for some underlying condition, and 22 (85%) of them had 
received antibiotics previously. Six patients died. In two of them, death was a consequence of their underlying disease 
and in  the remaining four, death was related to  the C. striaturn infection. 
Conclusions: C. striaturn, a microorganism traditionally considered to  be an avirulent member of the normal human 
nasopharyngeal and skin flora, may opportunistically cause infections in hospitalized patients with underlying diseases 
and previous antibiotic treatments. 
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INTRODUCTION 
Coryneform bacteria other than Corynebacterium 
diphtheriae have often been considered as colonizers or 
contaminants [l]. More recently, due in part to 
improved microbiological techniques, the survival of 
immunocompromised patients and increased use of 
medical devices, the clinical importance of these 
microorganisms has been recognized, particularly as a 
cause of opportunistic infection [l-31. Recent changes 
in the taxonomy of coryneform bacteria make it 
Corresponding author and reprint requests: 
L. Martinez-Martinez, Department of Microbiology, Hospital 
Universitario Virgen Macarena, Apdo 914, 41080, Seville, 
Spain 
Tel: +34 95 4552862 Fax: +34 95 4377413 
Accepted 1 July 1997 
difficult at this moment to evaluate the actual impor- 
tance of particular species of the genus Corynebacterium 
as a cause of infections in humans [3]. Most of the 
reports refer to C .  jeikeium [4-61 or C. urealyticum [7,8] 
and, to a lesser extent, to C .  amycolatum [9], C. 
pseudodiphtheriticum [10,11], and C. glucuronolyticum 
[12]. The significance and prevalence of most other 
coryneform bacteria (including genera other than 
Corynebacterium) are not well known. 
C .  striaturn has been isolated as part of the normal 
human nasopharyngeal flora and from the skin of the 
cheek, forehead and the upper part of the trunk [13]. 
Several case reports [14-261 and two series [27,28] 
comprising six and three cases respectively have been 
published. Person-to-person transmission of C. striaturn 
in intensive care units has been reported, but with 
limited clinical information [29,30]. We have pre- 
viously reported the microbiological identification of 
31 C. striaturn strains isolated from 24 patients in the 
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period January 1991 to October 1993 [31]. Unfortun- 
ately, clinical data concerning these 24 patients were 
incomplete in many cases. In this report we present the 
clinical data from patients (with complete clinical 
records available) from whom C. striaturn was isolated 
in the period January 1991 to July 1995. 
MATERIAL AND METHODS 
Patients 
We reviewed the clinical charts of patients from whom 
C. striaturn was isolated during the period January 1991 
to July 1995 at the Hospital Universitario Virgen 
Macarena (Seville, Spain), an 800-bed teaching hospital 
with a laboratory receiving samples from the hospital 
and outpatient clinics. Isolates of C. striaturn obtained 
from sterile fluids, catheters (2 15 CFU by the rolling- 
plate method), urine culture ( 1 2  species, >lo5 
CFU/mL) and pure or predominant culture from 
wound exudates and bronchial aspirates obtained with 
a bronchoscopic catheter were considered potentially 
significant. 
The clinical charts of patients from whom poten- 
tially significant C. striaturn strains were cultured were 
assessed according to CDC criteria [32] in order to 
define infection. In the case of surgical wounds and 
ulcers, diagnosis of infection by C. striaturn required 
isolation of the organism from the depths of the 
wound/ulcer and the presence of at least three of the 
following: redness, swelling, heat, pain hypersensitivity 
and abscess formation. In addition to the CDC criteria, 
a further requirement was for the physician in charge 
of the patient to suspect an infectious process at the site 
from which C. striaturn was isolated, and that, after 
isolation of the organism, a change in treatment should 
be effected: surgical debridement, antibiotic treatment 
with agent(s) to which the organism was susceptible in 
vitro, or catheter removal. 
The data from clinical charts indicated in Table 1 
were recorded for this study. 
Microbiological studies 
Clinical samples submitted to the microbiology labor- 
atory were processed according to conventional 
methods, as previously described [31]. C. striaturn 
strains isolated from January 1991 until October 1993 
were identified using conventional tests, the API 
CORYNE system, and cellular fatty acid profiles, as 
previously described [31]. The remaining isolates were 
identified with the API CORYNE system and conven- 
tional tests. Strains identified by the API CORYNE 
system as maltose-negative C. xerosis (presumably C. 
arnycoluturn in view of the new available data [9]), that 
could be misidentified as C. striaturn, were excluded on 
the basis of the morphology of the organism in Gram’s 
stain, colonial morphology, time to ferment sugars, and 
hydrolysis of tyrosine [31]. 
RESULTS 
In the study period, C. striaturn was isolated from 
clinical samples from 127 patients. Only 26 patients 
(from whom 38 isolates were obtained) fulfilled the 
strict criteria established for the diagnosis of infection. 
The remaining 101 patients were excluded either 
because the clinical charts were incomplete for evalua- 
tion purposes (49 patients), or because the organism 
was considered a colonizer (52 patients) according to 
the CDC criteria for definition of infection. 
C. striaturn was isolated as single agent in 25 out of 
the 26 infected patients. In the remaining case (patient 
no. 22), C. striaturn and Fusobacterium nucleaturn were 
isolated from a skin abscess over an arteriovenous 
fistula, whilst C. striaturn on its own was also recovered 
from blood cultures. In 16 (62%) patients, C. striaturn 
was cultured from skin chronic ulcers or surgical 
wounds. The organism was also recovered from blood 
in one patient, as previously stated, from bronchial 
lavage in four (15%), from intravenous catheter in two 
(8%), and from pleural fluid, peritoneal fluid, urine and 
the exudate from a balanoprepucial inflammation in 
one (4%) patient each. 
Clinical characteristics of the 26 patients are 
summarized in Table 1. There were 20 (77%) males and 
six (23%) females. The mean age was 58.5 years (range 
22-84). Fever (238°C) was present in 21 (80%) patients 
and leukocytosis (210 000 cells/mL) in 16 patients 
(62%). AU the patients were hospitalized and had an 
underlying systemic condition or had undergone 
surgery, or both. The mean previous hospital stay was 
20.7 days (range 3-50). The associated conditions were 
surgery in 12 (45%) cases, neoplasia in six (22%), 
tuberculosis in three (ll%), diabetes mellitus in five 
(19%), chronic obstructive lung disease in two (8%), 
and heart failure in two (8%). AU patients were HIV 
negative. 
All patients but one (a patient with intravenous 
catheter infection) presented local signs of inflam- 
mation, three of them with abscess formation. Twenty- 
two patients (85%) were receiving antibiotic therapy 
when C. striaturn was isolated, and 15 of them (58%, 
including three patients on antituberculous drugs) were 
receiving more than one antimicrobial agent. Nine of 
these patients were receiving a p-lactam which could 
be considered active in vitro against the corresponding 
C. striaturn isolate. The remaining 13 patients were 
receiving an antimicrobial agent to which C. striaturn 
was resistant in vitro (data not shown). 
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Table 1 Summary of data 
Previous 
Age/ Type of Underlying Source of Previous hospital stay Antibiotic 
Patient sex infection condition isolate antibiotic (days) treatment Outcome 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13  
14 
15 
I 6  
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
72/F Leg ulcer, sepsis Diabetes, neuropathy Ulcer aspirate CIP, C C  
59/M Surgical wound Larynx neoplasia Wound aspirate CC, TB 
64/F Bronchopneumonia COPD, tuberculosis Bronchial aspirate INH, PYZ, RIF 
74/M IV catheter, Hip replacement IV catheter CRX, FOX 
66/M Surgical wound Vertebral plasmocytoma Wound aspirate FIX 
28/F Plantar ulcer Diabetes, neuropathy Ulcer aspirate CIP, TB 
66/M Surgical wound Hip replacement, gastric Wound aspirate CTX, FOX, MTD 
phlebitis 
perforation 
52/M Bronchopneumonia Pneumectomy, lung 
27/M Empyema 
64/M Cystitis 
24/M Surgical wound 
68/M Spontaneous 
peritonitis 
78/F Leg ulcer 
66/M Surgical wound 
82/M Balanitis 
30/M Decubitus ulcer 
54/M Bronchitis 
68/F Surgical wound 
69/M IV catheter 
22/M Surgical wound 
59/M Bronchitis 
50/F AV fistula 
67/M Surgical wound 
84/M Leg ulcer 
56/M Leg ulcer 
75/M Leg ulcer 
cancer 
Cerebral hemorrhage 
Penis reconstruction 
Multiple trauma 
Metastatic neoplasia 
Diabetes, neuropathy 
Cavum neoplasia, 
tuberculosis 
Diabetes. Pancreatitis 
Spina bifida 
Heart failure 
Cholecystectomy 
Heart falure 
Teratocarcinoma 
COPD, tuberculosis 
Chronic renal failure 
Gastrectoniy 
Varices 
Cirrhosis 
Diabetes 
Bronchial aspirate 
Pleural fluid 
Urine 
Wound aspirate 
Peritoneal fluid 
Ulcer aspirate 
Wound aspirate 
Exudate 
Ulcer aspirate 
Bronchial aspirate 
Wound aspirate 
IV catheter 
Wound aspirate 
Bronchial aspirate 
Blood, abscess 
aspirate 
Wound aspirate 
Ulcer aspirate 
Ulcer aspirate 
Ulcer aspirate 
CAZ, CIP 
CTX, AZT, VAN 
AMX/CLAV 
AZT, CTX 
None 
CIP 
INH, PYZ, RIF 
AMX/CLAV 
FURAX 
AMX/CLAV 
CIP 
None 
cc 
INH, PYZ, RIF 
None 
CIP, CC 
CLX 
None 
CIP, C C  
3 
9 
30 
13 
22 
3 
45 
24 
11 
20 
50 
40 
20 
30 
30 
10 
27 
19 
10 
41 
25 
3 
19 
8 
12 
16 
CEF 
VAN 
VAN 
None 
CIP 
AMX/ 
CLAV 
AMP 
TEI 
MTD 
None 
None 
None 
AMP 
None 
None 
VAN 
VAN 
None 
AZT, 
VAN 
AZT 
VAN 
VAN, 
GEN 
VAN 
AMP 
None 
VAN 
Death 
Cure 
Death 
Cure 
Lost to 
Lost to 
Cure 
Death 
Death 
Cure 
Cure 
Death 
Cure 
Cure 
Cure 
Cure 
Cure 
Cure 
Death 
Cure 
Cure 
Cure 
Cure 
Cure 
Cure 
Improve- 
ment 
follow-up 
follow-up 
Note: CIP, ciprofloxacin;, CC, clindamicin; TB, tobramycin; INH, isoniazid; PYZ, pyrazinamide; RIF, rifampin; CRX,  ceftriaxone; FOX, 
cefoxitin; FIX, cefixime; CTX, cefotaxime; MTD, metronidazole; CAZ, ceftazidime; AZT, aztreonam; VAN, vancomycin; AMX/CLAV, 
amoxicillin/clavulanate; FURAX, nitrofurantoin; CLX, cloxacillin; AMP, ampicillin; TEI, teicoplanin; CEF, cefazolin; GEN, gentamcin; 
COPD, chronic obstructive pulmonary disease; AV, arteriovenons; IV, intravenous. 
The infection resolved in 17 (65%) patients: six 
were cured with surgical cleansing or catheter removal 
(but without antimicrobial therapy), six after surgical 
drainage plus antibiotic treatment, and five with 
antimicrobial treatment alone. Six patients died; five of 
them had received antimicrobial therapy, and one of 
them had not because of advanced metastatic disease. 
In two of them, death was clearly a consequence of 
the underlying condition (patients no. 12 and no. 20). 
In three patients (no. 1, no. 8 and no. 9), death was 
attributed to C. striaturn infection. Patient no. 6 had 
long-standing chronic obstructive lung disease and 
tuberculosis of recent diagnosis. C. striaturn infection 
may have contributed to the death of this patient. The 
remaining three (patients no. 5, no. 6, and no. 26) were 
lost to follow-up after an initial improvement. 
ILLUSTRATIVE CASE REPORTS 
The following cases are representative of the clinical 
characteristics of infection associated with C. striaturn. 
Case 9 has been previously reported [20]. 
Case 1 
A 72-year-old female patient, who had diabetes, hyper- 
tension and heart fdure, was admitted because of an 
infected ischemic ulcer in her right leg which had been 
unsuccessfully treated with oral ciprofloxacin (500 mg 
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PO b i d . )  and clindamycin (300 mg PO q id . ) .  The 
ulcer presented clear signs of infection. The patient was 
afebrile. The leukocyte count was 20 X 100/mm3, with 
93% neutrophils. In a needle aspirate of the ulcer, 
Gram-positive rods were observed within neutrophils 
and extracellularly; C. striaturn grew in pure culture 
from this sample and from a second sample obtained 
the next day. The patient was treated with cefazolin (2 g 
IV t i d . ) ,  but died of septic shock. 
Case 2 
A 59-year-old man presented with surgical wound 
infection after thyroidectomy for thyroid neoplasm. 
He  was put on clindamycin (600 mg IV. q.i.d.) and 
tobramycin (100 mg IV b i d . )  but the wound became 
purulent, with abscess formation. C. striatum was 
isolated in pure culture from a needle aspirate of the 
wound. The patient was treated with vancomycin 
(1 g IV b id . ) .  Two days later the organism was again 
cultured after surgical cleansing of the abscess. Vanco- 
mycin was continued for 10 days, with resolution of the 
infection. 
Case 3 
A 64-year-old woman with long-standing chronic 
obstructive lung disease was admitted to hospital 
because of pulmonary tuberculosis with severe respir- 
atory insufficiency requiring orotracheal intubation. 
Treatment with isoniazid, rifampin and pyrazinamide 
was started. After a transitory improvement, the patient 
again presented fever (38.7"C) and a marked respiratory 
deterioration. Chest X-rays revealed new infiltrates. 
Two separate bronchial aspirates with a protected 
catheter yielded a pure culture of C. striatum. The 
patient was started on vancomycin (1 g IV b i d . )  but 
her condition deteriorated and she died of respiratory 
failure 2 days later. 
Case 4 
A 74-year-old man admitted for total hip joint replace- 
ment and given intravenous cephalosporins for 10 days 
presented with fever (38°C) and signs of infection at  the 
intravenous catheter insertion site. More than 15 
colonies of C. striaturn grew in culture of the tip of the 
catheter by the rolling-plate method. The infection 
resolved without further antibiotic treatment. 
Case 22 
A 52-year-old woman with chronic renal failure had 
presented 7 months previously with signs of infection 
at the surgical scar of the arteriovenous fistula and the 
appearance of a deep skin sinus. Five months later, C. 
striaturn had been obtained in pure culture from the 
infection site, but was considered a contaminant, and 
the patient was not given antibiotic treatment. Fifteen 
days before the present adrmssion an abscess appeared 
over the fistula. The patient presented fever (38°C). 
The abscess drained spontaneously. Three days later 
C. striaturn was isolated from blood culture. Treatment 
was started with vancomycin (1 g IV b i d . )  but the 
patient remained febrile. The arteriovenous device was 
removed. C. striaturn and Fusobacteviurn nucleaturn were 
obtained from the culture of the device. The patient 
was cured after 3 weeks of intravenous vancomycin 
treatment. 
DISCUSSION 
The first case of C. striatum infection was published in 
1980 by Bowstead and Santiago in a patient with 
chronic lymphocytic leukemia who had a pleuro- 
pulmonary infection [15]. Since then, several case 
reports have been communicated, although not all cases 
present enough data to identify the organism: pulmon- 
ary infection in a patient with chronic obstructive 
airways disease [16] or in intubated patients [14,20], 
four cases of native valve endocarditis [18,22,25,26], 
one case of pacemaker-related endocarditis [23], two 
cases of bacteremia [17,19] and one case of meningitis 
[24]. Two series have been published, including three 
and six patients, respectively [27,28]. The isolated 
microorganisms were obtained from various sources 
(sputum, vaginal exudate, blood, intravenous catheter, 
peritoneal fluid, skin, conjunctiva and, in one patient, 
from uterus, placenta and urine). All patients from both 
series recovered after antibiotic treatment or surgery. 
Leonard et a1 [29] have reported the isolation of 
C. stviaturn in 11 patients. Some of these patients 
experienced improvement after antibiotic treatment, 
although the authors had no clearcut evidence that 
these isolates were acting as opportunistic pathogens. 
Recognition of C. striatum as a human pathogen 
may have been hindered by the inability of the clinical 
laboratory to identi@ the organism because its colonies 
may be confused with those of coagulase-negative 
staphylococci [31]. Moreover, C. striatum may be 
misidentified as a species of coagulase-negative staphy- 
lococcus when some automated method of identi- 
fication/susceptibility testing is used. For these reasons, 
a Gram stain is critical in order to identify C. striaturn. 
Even if this is carried out, there may be problems in 
correctly identifying the bacterium, particularly when 
there is exclusive reliance on the API CORYNE 
system, since strains of C. arnycolaturn (previously C. 
xerosis) may be misidentified as C. striatum when using 
this system [3,31]. Colonial morphology, time to 
ferment sugars and hydrolysis of tyrosine help to 
differentiate the species [3,31]. 
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C. striaturn was isolated in some of our patients 
from sources (ulcers and surgical wounds) where 
the organism could be considered a contaminant or 
colonizer. However, we believe that our inclusion 
criteria minimize this possibility. In fact, such rigorous 
criteria may account for the high percentage of isolates 
considered as colonizers or contaminants, and it might 
be suggested that the actual incidence of human 
infections caused by C. striaturn may be even higher 
than that presented in this report. A prospective study 
is in progress to evaluate this possibility. 
From the published cases it seems that most but not 
all patients have been hospitalized and have had an 
underlying or associated disease. In this report the 
majority of our patients had been hospitahzed for many 
days. The patients in our series presented hetero- 
geneous underlying conditions, including neoplasia in 
six  patients, diabetes in five and, surprisingly, tuber- 
culosis in three. A case-control study should be 
performed to assess whether these and other factors are 
related to C. striaturn infection. 
Leonard et al have presented evidence of trans- 
mission of a single C. striaturn strain in 11 hospitalized 
patients in an intensive care unit (ICU) [29]. More 
recently Brandenburg et al [30] have shown long- 
term persistence of C. striaturn in a surgical ICU 
affecting 14 mechanically ventilated patients. The 
strains were proven to be the same by means of 
biotyping, antibiotyping, and random amplification of 
polymorphic DNA. Patient-to-patient transmission 
probably occurred via hands of personnel. In a third of 
our cases the organism was also obtained from patients 
in the ICU, although the epidemiological relationship 
of these isolates has not yet been established. 
Corynebacteria in general have been most fre- 
quently isolated from the skin and mucosae of patients 
who have received broad-spectrum antibiotics [18], as 
was the case with most of our patients. Eight out of 11 
(73%) patients in the series by Leonard et al [29] had 
received p-lactam antibiotics, primarily cephalosporins 
and penicillins, before the isolation of C. striaturn. In 
our case (Table l) ,  22 out of 26 (85%) patients were 
receiving antimicrobial agents (mainly beta-lactams, 
ciprofloxacin and/or clindamycin); three patients were 
being treated for tuberculosis with rifampin, isoniazid 
and pyrazinamide. Considering the NCCLS break- 
points for non-fastidious bacteria [33], the organism 
was resistant in vitro to the antimicrobial agent($ used 
at the moment of the isolation in 13 of these 22 
patients. Unfortunately, definition of susceptibility and 
resistance to antimicrobial agents in C. striaturn (and 
other coryneform bacteria) is difficult because break- 
points are not yet available specifically for this group of 
organisms. Moreover, Tattevin et al [25] have shown 
high Ml3C values of amoxycillin and ceftriaxone (128 
and 64 pg/mL, respectively) compared to MIC values 
(1 and 8 p g / d ,  respectively), which makes it even 
more difficult to correlate in vitro susceptibility testing 
of C. striaturn with in vivo results. 
Seventeen patients were cured of their dection: six 
after surgical cleansing and/or catheter removal; five 
after antimicrobial therapy; and s i x  after both surgical 
cleansing/catheter removal and antimicrobial therapy. 
Six patients died, one of them without receiving any 
treatment because of the severity of his underlying 
disease; an additional patient received antimicrobial 
therapy with an agent to which his isolate was resistant 
in vitro. Three patients died in spite of being treated 
with antimicrobial agents active in vitro. All s i x  patients 
were previously severely debilitated. Additionally, anti- 
microbial therapy based on in vitro susceptibility data 
was often delayed because of the time (about 2-3 days 
after the sample was obtained) required for identification 
and susceptibility testing of C. striaturn. It seems fbm 
this series that the underlying condition and the local 
measures taken are as important as the antimicrobial 
treatment in the prognosis of these patients. 
With the improvement of microbiological tech- 
niques and the survival of patients with underlying 
disease and/or immunosuppression, C. striaturn may be 
recognized as a cause of infection with different degrees 
of severity in hospitalized patients. 
In conclusion, the results from this study show 
the role of C. striaturn as a cause of human infection, 
particularly in hospitalized patients with underlying 
diseases, and previous antimicrobial agent treatments. 
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